FindTrial
Sign In

To compare intubating conditions with and without priming with rocuronium

A prospective randomized study in comparing intubating conditions with and without priming with rocuronium - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075144
Enrollment
60
Registered
2024-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Rocuronium: One tenth of intubation dose of rocuronium 0.06mg/kg rocuronium as priming dose to be given intravenously 3minutes prior to giving remaining intubating dose of 0.54mg/kg roc

Sponsors

Dr Imnasenla Ozukum
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient undergoing general anaesthesia giving consent to participate in study and age group between 18 to 60 years with mallampati grade 1 and 2

Exclusion criteria

Exclusion criteria: Patient refusal Age more than 65 years History of allergy to rocuronium History of patients receiving drugs interfering with neuromuscular action Obesity Mallampati grade 3 and 4

Design outcomes

Primary

MeasureTime frame
1.Rocuronium 0.06mg/kg is expected to produce acceptable intubating conditions (good or excellent). Timepoint: 60 seconds—

Secondary

MeasureTime frame
2. Rocuronium is expected to not show any adverse hemodynamic response. Timepoint: 60 seconds—

Countries

India

Contacts

Public ContactDr Imnasenla Ozukum

Gajra Raja Medical college, Gwalior, Madhya Pradesh

drpreetiravigoyal@gmail.com9424455330

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026